Skip to content

TuHURA Biosciences, Inc. HURA Other Income (Expense)

Other Income (Expense) at other companies

CTO
Citius Oncology, Inc.CTOR
$1.77M+4,003%
Inhibrx Biosciences, Inc. logo
Inhibrx Biosciences, Inc.INBX
-$2.51M-513%
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
-$563M-760%
Avalo Therapeutics logo
Avalo TherapeuticsAVTX
$1.28M-16.0%
Janux Therapeutics logo
Janux TherapeuticsJANX
$9.85M-13.5%
Vera Therapeutics logo
Vera TherapeuticsVERA
$4.1M-25.5%

Other financials

Income statement

See full
Revenue-
Net income-$7.5M-13.1%
EPS (diluted)-$0.13+13.3%

Balance sheet

See full
Cash & equivalents$6.3M+1.3%
Total debt$456.9K+178%
Total equity$23.2M+135%
Total assets$29.7M+103%

Cash flow

See full
Operating cash flow-$4.4M+6.9%
CapEx$48.8K+14.5%
Free cash flow-$4.5M+6.7%

Valuation

See full
Market cap$155.39M+45.8%
Enterprise value$149.54M+52.3%

Returns & leverage

See full
Return on equity-187.2%
Debt / equity0.0×
Current ratio1.2×-1.8×

Where this comes from

Reported directly by TuHURA Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.

The official record: TuHURA Biosciences, Inc.’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about TuHURA Biosciences, Inc.'s other income (expense).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is TuHURA Biosciences, Inc.'s other income (expense)?
TuHURA Biosciences, Inc. (HURA) reported other income (expense) of -$6.7K in Q1 2026.
How has TuHURA Biosciences, Inc.'s other income (expense) changed year-over-year?
TuHURA Biosciences, Inc.'s other income (expense) decreased by 101.9% year-over-year, from $352.65K to -$6.7K.
What is the long-term trend for TuHURA Biosciences, Inc.'s other income (expense)?
Over 2 years (2023 to 2025), TuHURA Biosciences, Inc.'s other income (expense) has grown at a 244.4% compound annual growth rate (CAGR), from $147K to $1.74M.
What does other income (expense) mean?
Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.